Alzheimer’s disease is a type of dementia. Alzheimer Center Amsterdam aims to find ways to discuss, treat and cure Alzheimer’s disease and other types of dementia. Read here about our latest insights and activities.
Alzheimer's diagnosis shortly based on biomarkersAt the International Alzheimer's Congress (AAIC) 2023 in Amsterdam, new guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented. In these criteria, the disease is diagnosed in the clinic through the use of blood biomarkers, just as with other major diseases such as diabetes and cardiovascular disease.
In search of the role of our immune system in Alzheimer's Disease Amsterdam UMC increasingly shines a light on the role of the immune system in Alzheimer's offering a new perspective in the hunt for an effective treatment. Today, Professor Elga de Vries is awarded an ERC Advanced Grant of €2.5m to continue this, with the BRAIN Project.
Alzheimer's double punishment: Women get it more and do more care giving"Women are both disproportionately affected by Alzheimer's Disease while also bearing the bulk of the caregiving burden," concludes Wiesje van der Flier, Scientific Director of the Alzheimer Center Amsterdam at Amsterdam UMC. For van der Flier, more research is necessary. Not only about how the disease develops biologically in males and females, but also how the gender of caregiving determines the care provided.
Opening the blood-brain barrier with ultrasoundFor the first time in Europe, researchers are trying to temporarily open the blood-brain barrier in a non-invasively manner. They do this using an innovative technique applying low-focused ultrasound (FUS). This will allow drugs to reach the brain more easily.